Glykos has a total of 455 patents globally, out of which 166 have been granted. Of these 455 patents, more than 24% patents are active. United States of America is where Glykos has filed the maximum number of patents, followed by Finland and Europe (EPO). Parallelly, Finland seems to be
Hybio Pharmaceutical has a total of 774 patents globally, out of which 482 have been granted. Of these 774 patents, more than 38% patents are active. China is where Hybio Pharmaceutical has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, China seems
Actics Medical has a total of 12 patents globally, out of which no patents have been granted. Of these 12 patents, more than 83% patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also Israel is the origin country of Actics Medical.
1E Therapeutics has a total of 32 patents globally, out of which 2 have been granted. Of these 32 patents, more than 84% patents are active. United States of America is where 1E Therapeutics has filed the maximum number of patents, followed by Europe (EPO) and Australia. Parallelly, United States
Abbott has expanded its presence across various industries through strategic acquisitions and subsidiaries. By acquiring companies in sectors like medical devices, diagnostics, and nutrition, Abbott has strengthened its portfolio and market reach. By expanding its portfolio, Abbott continues to innovate and address the changing needs of the healthcare market, providing
Pfizer has grown its presence in various industries through smart acquisitions and subsidiaries. These acquisitions have allowed Pfizer to strengthen its product offerings and services, diversify its portfolio, and enhance its capabilities in key areas such as biotechnology, vaccines, and healthcare innovation. By integrating new technologies and expertise from acquired
Penwest Pharmaceuticals has a total of 234 patents globally, out of which 105 have been granted. Of these 234 patents, more than 1% patents are active. Europe (EPO) is where Penwest Pharmaceuticals has filed the maximum number of patents, followed by Japan and India. Parallelly, United States of America seems
Intas Pharmaceuticals has a total of 571 patents globally, out of which 146 have been granted. Of these 571 patents, more than 77% patents are active. India is where Intas Pharmaceuticals has filed the maximum number of patents, followed by United States of America and Europe (EPO). Parallelly, India seems
Omthera Pharmaceuticals has a total of 113 patents globally, out of which 50 have been granted. Of these 113 patents, more than 30% patents are active. The United States of America is where Omthera Pharmaceuticals has filed the maximum number of patents, followed by Hong Kong (S.A.R.) and China. Parallelly,
Kashiv Biosciences has a total of 241 patents globally, out of which 31 have been granted. Of these 241 patents, more than 60% patents are active. The United States of America is where Kashiv Biosciences has filed the maximum number of patents, followed by India and Canada. Parallelly, India seems
Interested in in-depth patent data and patent portfolio analysis of Tesla. Get your report now.